Researchers Find Treatment Options for Patients Whose Blood Cancer Relapses After CAR-T

[ad_1]

“This is the first study to report outcomes of different therapeutic options given to a large cohort of patients who relapsed after anti-BCMA CAR-T therapy,” Dr. Samir Parekh said.

Mount Sinai and Memorial Sloan Kettering Cancer Center (MSK) researchers have identified therapies that can help patients with the blood cancer multiple myeloma who try an immunotherapy known as CAR-T only to find their cancer coming back afterwards.

CAR-T, short for chimeric antigen receptor T-cell therapy, enlists immune cells called T cells to fight multiple myeloma by altering them in the lab so they can find and destroy cancer cells. It has been a revolutionary treatment for this deadly cancer, but some patients relapse after receiving CAR-T therapy and have no good treatment options afterward.

In a new study published in the journal Blood in November, the researchers studied a large group of multiple myeloma patients who were given several different therapies when they relapsed after receiving a type of CAR-T cell therapy called BCMA-directed CAR-T. This version of CAR-T cell therapy targets the BCMA protein on cancerous plasma cells in order to fight multiple myeloma.

The researchers found that other therapies that engage T cells, including bispecific antibodies and other types of CAR-T cell therapy, appear to have the most pronounced success in knocking down these relapsed patients’ cancer for the greatest length of time.

“The findings of this study will serve as a benchmark for future prospective clinical studies that intend to improve the outcomes of patients who progress after CAR-T,” said a senior author on the study, Samir Parekh, MD, Director of Translational Research in Multiple Myeloma and co-leader of the Cancer Clinical Investigation program at The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai. “This is the first study to report outcomes of different therapeutic options given to a large cohort of patients who relapsed after anti-BCMA CAR-T therapy. This is one of the most urgent and unmet needs in myeloma patients and, therefore, of great interest to the hematology community.”

This retrospective study analyzed 79 patients’ disease characteristics, the treatments given after relapse, and the patients’ responses to the therapies. Patients’ median overall survival to date is about 18 months.

Stem cell transplants also showed some efficacy in these patients. Other drug combinations can also be used with variable efficacy based on the characteristics of individual patients’ cancer, the study found.

The patients were treated at The Tisch Cancer Institute and MSK.

“We’re encouraged that subsequent use of other novel immune therapies like a second CAR-T cell therapy or a bispecific antibody was feasible and led to durable responses in patients,” said Sham Mailankody, MBBS, Associate Attending Physician, MSK, and senior author on the paper. “We look forward to continuing this work and unlocking the full potential of immune therapies for patients with multiple myeloma.”

About the Mount Sinai Health System

Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.

Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report’s Best Hospitals, receiving high “Honor Roll” status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children’s Hospital among the country’s best in several pediatric specialties. The Icahn School of Medicine at Mount Sinai is one of three medical schools that have earned distinction by multiple indicators: It is consistently ranked in the top 20 by U.S. News & World Report’s “Best Medical Schools,” aligned with a U.S. News & World Report “Honor Roll” Hospital, and top 20 in the nation for National Institutes of Health funding and top 5 in the nation for numerous basic and clinical research areas. Newsweek’s “The World’s Best Smart Hospitals” ranks The Mount Sinai Hospital as No. 1 in New York and in the top five globally, and Mount Sinai Morningside in the top 20 globally.

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

Share article on social media or email:

[ad_2]

Employment Lawyers, at Blumenthal Nordrehaug Bhowmik De Blouw LLP, File Suit Against Best Practice Medicine, LLC, for the Alleged Wrongful Termination of Employee

[ad_1]

Law Office of Blumenthal Nordrehaug Bhowmik De Blouw LLP

For more information about the class action lawsuit against Best Practice Medicine, LLC, call (800) 568-8020 to speak to an experienced California employment attorney today.

The Los Angeles employment law attorneys, at Blumenthal Nordrehaug Bhowmik De Blouw LLP, filed a class action lawsuit against Best Practice Medicine, LLC alleging the company violated the California Labor Code. The lawsuit against Best Practice Medicine, LLC is currently pending in the Kern County Superior Court, Case No. BCV-22-102688. To read a copy of the Complaint, please click here.

According to the lawsuit filed, Best Practice Medicine, LLC allegedly failed to pay employees for all the time they were under the employer’s control. This, allegedly, includes the time Plaintiff and other California Class Members had to submit to mandatory COVID-19 questionnaires and temperature checks prior to clocking in for the day. To the extent that the time worked off, the clock did not qualify for overtime premium payment, Defendant allegedly failed to pay minimum and overtime wages for the time worked off-the-clock.

The complaint further alleges Plaintiff was wrongfully terminated. Plaintiff engaged in protected activity by complaining to Defendant of Defendant’s alleged illegal employment practices, related to the alleged failure to follow the California Labor Code wage and hour laws. Shortly after, Plaintiff complained to his supervisor(s) of the alleged unlawful employment practices, Defendant terminated Plaintiff’s employment. Therefore, there is an alleged casual link between the protected activity and the company’s decision to terminate Plaintiff.

For more information about the class action lawsuit against Best Practice Medicine, LLC, call (800) 568-8020 to speak to an experienced California employment attorney today.

Blumenthal Nordrehaug Bhowmik De Blouw LLP is a labor law firm with law offices located in San Diego County, Riverside County, Los Angeles County, Sacramento County, Santa Clara County, Orange County, and San Francisco County. The firm has a statewide practice of representing employees on a contingency basis for violations involving unpaid wages, overtime pay, discrimination, harassment, wrongful termination, and other types of illegal workplace conduct.

***THIS IS AN ATTORNEY ADVERTISEMENT***

Share article on social media or email:

[ad_2]

AHN Sleep Specialist Offers Tips for Adjusting to Fall Time Change

[ad_1]

News Image

“Particularly for those who are sleep deprived, the extra hour of sleep this weekend is not enough to erase a person’s total sleep debt,” said Dr. Shade.

This Sunday, Nov. 6 at 2 a.m., Daylight Saving Time (DST) will end in Western Pennsylvania and clocks will ‘fall back’ one hour. Ahead of the fall time change, which is marked by shorter days and earlier sunsets, an Allegheny Health Network (AHN) sleep specialist is sharing tips for how to adjust to the change and minimize its potential negative health impacts.

Although many will gain one hour of sleep with the switch from DST to standard time, Dan Shade, MD, sleep medicine specialist and director of the AHN Sleep Disorders Center, says any disruption to a person’s sleep pattern can contribute to short- and long-term health issues.

“While a one-hour change in time might not seem significant, even slight changes made to our bodies’ natural circadian rhythms increase the risk for serious health problems such as insomnia and depression, as well as poor immunity,” said Dr. Shade.

Often referred to as the body’s internal alarm clock, circadian rhythms help people fall asleep at night and wake up in the morning. Since they are primarily regulated by sunlight, Dr. Shade says a common challenge for people during the winter months is getting enough sunlight exposure and maintaining sufficient levels of vitamin D for proper sleep.

To help individuals prepare for the end of DST and maintain wellness related to sleep throughout the remaining fall and winter months, Dr. Shade suggests the following:


  • Go to bed at the same time as you normally would the evening before the time change on Saturday, Nov. 5.
  • Limit exposure before bed to devices which emit high-energy blue light and affect melatonin levels.
  • Take extra care to support your body’s immune system until your body has adjusted to the change (usually within a few days) by eating a healthy diet, exercising and resting as needed.
  • Expose yourself to natural sunlight in the morning to help your body sync with the new sleep schedule.
  • Utilize light boxes or desk lamps which simulate sunlight, particularly on darker winter days, to help reset circadian rhythms and minimize risk for developing seasonal affective disorder (SAD).
  • Continue exercise habits to positively impact depth of sleep.
  • Consult with your doctor about whether taking a vitamin D supplement is right for you.

According to the NIH, about 50 to 70 million Americans have sleep disorders, and 1 in 3 adults do not regularly get the recommended uninterrupted sleep they need to protect their health.

“Particularly for those who are sleep deprived, the extra hour of sleep this weekend is not enough to erase a person’s total sleep debt. Regularly practicing healthy sleep habits will aid in getting enough sleep which, for most, is between 7 and 8 hours each night,” said Dr. Shade.

To learn more about the AHN Center for Sleep Medicine which provides a range of services for the diagnosis and treatment of sleep disorders, visit http://www.ahn.org/services/medicine/sleep. To schedule an appointment, call (412) DOCTORS.

###

About Allegheny Health Network

Allegheny Health Network (AHN.org) is an integrated healthcare delivery system serving the greater Western Pennsylvania region. The Network is composed of 14 hospitals, ambulatory surgery centers, Health + Wellness Pavilions, an employed physician organization, home and community-based health services, a research institute and a group purchasing organization. The Network provides patients with access to a complete spectrum of advanced medical services, including nationally recognized programs for primary and emergency care, cardiovascular disease, cancer care, orthopedic surgery, neurology and neurosurgery, women’s health, diabetes and more. AHN employs approximately 21,000 people, has more than 2,600 physicians on its medical staff and serves as a clinical campus for Drexel University College of Medicine and the Lake Erie College of Osteopathic Medicine.

Share article on social media or email:

[ad_2]

Harmony Healthcare IT Rated No. 1 for Fourth Year in Data Archiving, Extraction and Migration in Black Book™ Survey

[ad_1]

“This industry recognition reflects our relentless dedication and broad expertise with more than 550 software brands,” said Tom Liddell, CEO of Harmony Healthcare IT.

Harmony Healthcare IT, a first-to-market innovator of legacy data management solutions such as HealthData Archiver®, HealthData AR Manager™ and HealthData Locker™, has been named the industry leader in data archiving, data extraction and migration for the fourth year in a row (2019-2022), according Black Book™ Rankings, a division of Black Book™ Market Research.

The 2022 award is based on a survey of 2,996 medical practices, hospitals, and healthcare organizations to determine the top-performing vendors among in-demand computer-assisted coding, clinical documentation improvement software, speech recognition, transcription systems, and outsourced coding services, and to assess the gaps and urgencies of coding technology administration.

The annual Black Book survey collects ballot results from healthcare executives and front-line users about their current technology and services partners and awards top-performing vendors based on performance on eighteen qualitative indicators of client experience, loyalty, and customer satisfaction, among other critical KPIs.

“This industry recognition reflects our relentless dedication and broad expertise with more than 550 software brands,” said Tom Liddell, CEO of Harmony Healthcare IT. “Our team extracts, migrates and archives data from the widest variety of clinical, financial, and business systems used in healthcare delivery organizations nationwide. We are pleased to be a trusted resource for providers of all sizes who are adapting to the 21st Century Cures Act regulations and other best practices for lifecycle health data management.”

To assist healthcare delivery organizations with health data management, Harmony Healthcare IT has developed a suite of products and services that consolidates data stores, reduces out-of-production system maintenance costs, mitigates technical risk, complies with record retention mandates, and offers both interoperability and data analytics capabilities.

To start, customers’ legacy systems get inventoried and prioritized in an online application rationalization tool called HealthData Planner™. As decisions are made to decommission a legacy system, structured and unstructured data is either extracted and converted to a go-forward system (i.e., Epic, Cerner, MEDITECH) or migrated and secured onto one of the company’s active archive solutions, HealthData Archiver® or HealthData AR Manager™.

Records are then activated for interoperability with other systems, entities or consumers via HealthData Integrator™, which provides a set of tools or APIs based on common industry standards such as USCDI, FHIR, HL7, C-CDA, XML, or Direct. This also helps enable compliance with regulations of the 21st Century Cures Act.

About Harmony Healthcare IT

Harmony Healthcare IT is a data management firm that moves and stores patient, employee, and business records for healthcare organizations. To strengthen care delivery and improve lives, vital information is preserved and managed in a way that keeps it accessible, usable, interoperable, secure, and compliant. Since 2006, its US-based team of experts has worked with over 550 unique clinical, financial, and administrative software brands used in U.S. and Canadian healthcare delivery organizations. Harmony Healthcare IT has been consistently ranked as the #1 data extraction, migration, and archival healthcare IT company according to Black Book™ Market Research for four years (2019-2022) as well as ranked #1 in the 2020 Best in KLAS Software & Services Report as a Category Leader in Data Archiving.

For more information about Harmony Healthcare IT, visit: http://harmonyhit.com.

About Black Book

Black Book Market Research LLC, its founder, management, and staff do not own or hold any financial interest in any of the coding, health information management, and revenue cycle solutions vendors covered and encompassed in the surveys it conducts. Black Book reports the results of the collected satisfaction and client experience rankings in publication and to media before firm notification of rating results and does not solicit survey participation fees, review fees, inclusion, or briefing charges, or involve consultant firm collaboration with Black Book before the announcement of the polling outcomes.

In 2009, Black Book began surveying the client experience of healthcare software and managed services users, as well as polling for trend identification, industry insights, and outcomes. Black Book expanded its survey prowess and reputation of independent, unbiased crowd-sourced surveying to technology professionals, physician practice administrators, clinicians, user-level staff, financial leaders, executives, and board members. Consultants and advisor satisfaction polls were first issued in 2011. In 2012, Black Book included payer organizations and insurers, and in 2015, launched panel surveying of healthcare consumers. Medical capital equipment ratings will be available starting in Q4 2021.

Frequently asked questions about Black Book’s operations, practices, and transparency including recent reporting can be viewed at https://blackbookmarketresearch.com/FAQ

For Black Book vendor satisfaction rating methodology, auditing, resources, comprehensive research, and ranking data see http://www.blackbookmarketresearch.com

[ad_2]

Winners of 2022 Georgia CIO of the Year ORBIE Awards Announced

[ad_1]

GeorgiaCIO announced the winners of its 2022 CIO of the Year® ORBIE® Awards. GeorgiaCIO recognized chief information officers in seven key categories – Super Global, Global, Large Enterprise, Enterprise, Large Corporate, Corporate, & Healthcare. The Awards were presented at the Georgia CIO ORBIE Awards at Cobb Galleria.

“Every organization is technology-dependent, but strong leadership is the X-factor that can turn mundane IT into a remarkable strategic differentiator,” said Brandon Van Orden, GeorgiaCIO Chair. “The ORBIE Awards are meaningful because they are judged by peers – CIOs who understand the challenges of technology leadership.”

The 2022 Georgia CIO ORBIE Award winners are:

›› Jean Holley, Board Director, HERC Holdings Inc & Accord Financial Corp. received the Lifetime Achievement Award.

›› Vijay Raghavan, EVP & CTO, Lexis Nexis Risk Solutions Group received the Super Global ORBIE for organizations over $3 billion annual revenue & multi-national operations.

›› Daniel Volk, SVP, CIO, Crawford and Company received the Global ORBIE for organizations over $1 billion annual revenue & multi-national operations.

›› Mike Guhl, CIO, HD Supply received the Large Enterprise ORBIE for organizations over $2 billion annual revenue.

›› Dr. Tim Chester, VP for IT, University of Georgia received the Enterprise ORBIE for organizations over $1 billion annual revenue.

›› Scott Waid, SVP, Head of Technology, Atlanta Braves National League Baseball Club received the Large Corporate ORBIE for organizations $400 million annual revenue.

›› Elizabeth Hoemeke, CIO, One Inc received the Corporate ORBIE for organizations up to $400 million annual revenue.

›› Dr. Hank Capps, EVP, Chief Information & Digital Officer, Wellstar Health System received the Healthcare ORBIE for hospitals & healthcare organizations.

The CIO of the Year ORBIE Awards is the premier technology executive recognition program in the United States. Since inception in 1998, over 500 CIO of the Year winners have received the prestigious ORBIE Award. The ORBIE honors chief information officers who have demonstrated excellence in technology leadership. Finalists and winners are selected by an independent peer review process, led by prior ORBIE recipients, based upon:

›› Leadership and management effectiveness

›› Business value created by technology innovation

›› Engagement in industry and community endeavors

The Georgia CIO ORBIE Awards keynote was delivered by Jimmy Etheredge, CEO, Accenture, North America. Nearly 700 guests attended, representing leading Georgia organizations and their technology partners.

The 2022 Georgia CIO ORBIE Awards was made possible by the following sponsors:

›› Underwriters: Lumen, Google Cloud, Intellinet, Insight, & SoftServe, Inc.

›› Gold sponsors: Fortinet, Nagarro, New Relic Inc, Okta, Pariveda Solutions, STONE Resource Group, Twilio, Veristor + Anexinet

›› Silver sponsors: Appian Corporation, Capgemini, Comcast Business, Converge Technology Solutions, Darktrace, Grant Thornton International Ltd., Hylaine, Palo Alto Networks, Pluralsight LLC, ServiceNow, Slack Technologies, Tata Consultancy Services, VMware, Zscaler Inc

›› Bronze sponsors: Accenture, AHEAD, Amazon Web Services, Celsior Tech, Cloudflare, Cognizant, Cumberland Group, Emtec, Inc. GalaxE Solutions, IBM, iVision, Juniper Networks, Microsoft, Persistent Systems Inc, Primus Software Corporations, Protiviti, SHI International, Snowflake, Tanium, Tech Mahindra Americas, V-Soft Consulting Group

›› Media partner: Atlanta Business Chronicle

›› National partner: Year Up

›› About GeorgiaCIO

GeorgiaCIO is the preeminent peer leadership network of Georgia chief information officers. GeorgiaCIO is one of 25 chapters of the InspireCIO Leadership Network, a national membership organization comprised exclusively of CIOs from public and private businesses, government, education, healthcare and nonprofit institutions.

GeorgiaCIO is led by a CIO Advisory Board, supported by an executive director and staff. Underwriter executives ensure programs remain non-commercial and exclusive to qualified CIOs and members.

›› Achieve your leadership potential through GeorgiaCIO: http://www.GeorgiaCIO.org

›› Stay connected with GeorgiaCIO at: http://www.linkedin.com/company/GeorgiaCIO

[ad_2]

IDEX Health & Science Launches Innovative Avant™ Optical Filter Set Family

[ad_1]

News Image

“The developments made with our Avant Filters marks the first significant breakthrough in optical filter technology in years, which will have a lasting impact on the life science industry,” said Xavier El Baz, Sr. Product Manager.

IDEX Health & Science has extended its line of Semrock™ brand optical filters with the launch of the new Avant™ filter set family. This new filter set has been designed to provide significant improvement in fluorescence performance for corresponding short Stokes Shift fluorophores.

“The developments made with our Avant Filtersnull marks the first significant breakthrough in optical filter technology in years, which will have a lasting impact on the life science industry,” said Xavier El Baz, Sr. Product Manager.

While every fluorescent filter set has a Gap separating excitation and emission passbands, many sets for short Stokes Shift probes have large Gaps that shift the emission filter to longer wavelengths. The emission filter captures less fluorescence and the filter set’s performance is therefore reduced. Until now, limitations in the coating process and excessive bleed-through into the emission channel have resulted in lower-performing filter sets that impact many fluorescence systems today.

IDEX Health & Science’s new Semrock Avant technology narrows this Gap and brings the emission and excitation passbands close together. The Avant family of sets thereby deliver significant increases in fluorescence signal. This is achieved with steep spectral edges and high OD blocking of the excitation passband in the emission filter. The spectral features are confirmed by Semrock’s high-resolution KolaDeep™ Spectral Measurement System, and the new Precise Edge Placement capability assures that every filter set delivers consistent performance.

Learn More About Maximizing Fluorescence Performance with Avant

About IDEX Health & Science, LLC

IDEX Health & Science, LLC is the global leader in life science fluidics, microfluidics, and optics, offering a three-fold advantage to customers by bringing optofluidic paths to life with strategic partnerships, solutions, and expertise. As one of the few companies in the world with component, sub-system, and application level experts, IDEX Health & Science helps instrument developers solve the most demanding fluidic and optical challenges in a wide array of applications. At IDEX Health & Science we believe partnership will change the way the world innovates, leading to new technologies that improve our health, protect our planet, and enrich our lives. For more information visit: http://www.idex-hs.com

Share article on social media or email:

[ad_2]

Atarraya and BiomEdit Announce Research Collaboration to Increase Sustainability of Shrimp Farming and Improve Global Food Security

[ad_1]

Shrimp produced in Atarraya’s Shrimpbox using biofloc technology

“The findings from this research project will help Atarraya to increase the production output of shrimp farming while reducing costs and improving sustainability. Together, we are making shrimp the most sustainable protein choice in global food production.”

Atarraya Inc, creator of Shrimpbox, the first sustainable ‘plug-and-play’ shrimp farming technology, and BiomEdit, a microbiome innovator focused on animal health, today announced a research collaboration to investigate microbial changes to improve the cost-effectiveness, sustainability and production output associated with shrimp farming. The research partnership will focus on nitrifying microbes and vibriosis control, and will study how microbial communities change over time in a shrimp biofloc system to define the homeostasis of the ecosystem created for sustainable shrimp farming.

The goal of Atarraya and BiomEdit’s research collaboration is to gain a better understanding of microbial communities and their correlation with nitrogen spikes and other environmental changes. The knowledge gained from the study will help to minimize water usage, improve the environmental footprint of production and reduce the amount of feed needed to produce shrimp. This will improve the cost-effectiveness of sustainable shrimp farming significantly as feed is responsible for about 50% of shrimp production cost.

“Our collaboration with BiomEdit goes back to the core idea of Atarraya: using deep science knowledge to optimize protein production and contribute to global food security,” said Daniel Russek, CEO and founder of Atarraya. “The findings from this research project will help Atarraya to increase the production output of shrimp farming while reducing costs and improving sustainability. Together, we are making shrimp the most sustainable protein choice in global food production.”

Atarraya and BiomEdit expect to learn more about the ecosystem in aquaculture by using advanced microbiological tools to analyze the composition and diversity of microorganisms that inhabit the shrimp pond, as well as their interactions with each other and their environment.

“The Microbiome project will allow a deeper understanding of the role of the microbial community in maintaining crop homeostasis,” explains André Freitas, Biotech Director, Atarraya Inc. “The future of modern aquaculture is based on the use of innovative technology applied to high productivity systems, rational use of water and production of premium quality protein. Shrimp farming in a biofloc system is the face of this new aquaculture.”

Atarraya’s shrimp farming technology uses biofloc technology to transform waste nutrients into feed with the help of microorganisms. As part of the research collaboration, BiomEdit will use its gene-sequencing platform to provide critical insights into the roles of various microorganisms in the growth cycle of shrimp through high-throughput strain isolation and characterization. The approach is especially critical in land-based aquaculture systems with low environmental impact and increases the reliability of shrimp protein production. The research findings will be used to inspire strategies that optimize the health and performance of aquaculture shrimp production.

As one of the most popular proteins in the world, shrimp plays a key role in feeding a growing global population. In the past five years, shrimp sales volume increased from 275 to 415 million pounds. Yet, conventional methods of shrimp farming are disastrous for the environment – destroying seabeds and polluting oceans. Housed in a traditional shipping container, Shrimpbox by Atarraya is the key to meeting the growing demand for shrimp by increasing production while minimizing the impact on the planet.

“We are pleased to collaborate with Atarraya to find new ways to unlock the potential of the microbiome for shrimp producers who are trying to increase production and reduce their environmental footprint to meet the demands of a growing population,” said Aaron Schacht, CEO of BiomEdit. “Our deep knowledge in the microbiome in livestock paired with Atarraya’s immense expertise in shrimp and aquaculture production systems form an ideal match to optimize the use of biofloc.”

About Atarraya

Atarraya is on a mission to make shrimp the sustainable protein of the 21st century. Powered by AI, Atarraya’s proprietary Shrimpbox is a true “plug and play” sustainable shrimp farm that transforms aquaculture by using the most advanced biotechnology, software and hardware available. Atarraya’s Shrimpbox technology was developed over the course of the past 10 years by a team of engineers, biologists, and developers from Mexico, Norway, Brazil, Argentina and Poland. Atarraya’s holdings include Maricultura Vigas, a sustainable aquaculture production company with a decade of shrimp farming experience utilizing biofloc technology that minimizes the use of water and eliminates the necessity of antibiotics and harmful chemicals.

Based in Mexico City and Indianapolis, Atarraya is a privately held corporation backed by Jeffrey Horing, Mark K. Gormley and other angel investors. Follow Atarraya on YouTube, LinkedIn and Twitter, or learn more at https://www.atarraya.ai.

About BiomEdit

Founded in 2022 and headquartered in Fishers, Indiana, BiomEdit discovers, designs and develops novel probiotics, microbiome-derived bioactives and engineered microbial medicines to address unmet needs in animal health. We partner with Ginkgo Bioworks to amplify and accelerate product discovery and development with a goal of introducing breakthrough innovation for livestock producers and veterinarians. BiomEdit is Microbiome Innovation in Animal Health. For more information, visit us at linkedin.com/company/biomeditanimalhealth.

All trademarks contained herein are the property of their respective owners.

###

Share article on social media or email:



[ad_2]

Scientist.com Wins 2022 BioTech Breakthrough Award for “Overall BioPharma Solution of the Year”

[ad_1]

News Image

“We are thrilled to be a 2022 BioTech Breakthrough award winner. By eliminating paperwork and bureaucracy and creating a more automated and intelligent R&D process, Scientist.com is helping drive tomorrow’s great discoveries, today.”— Chris Petersen, Founder and CTO at Scientist.com.

Scientist.com, the biopharma industry’s leading R&D platform, announced it has been recognized as “Overall BioPharma Solution of the Year” in the second annual BioTech Breakthrough Awards program conducted by BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology companies, products and services around the globe. Scientist.com is the world’s largest platform for outsourced R&D, connecting global research organizations with contract research organizations (CROs) and enabling decentralized R&D. The custom-built, cloud native platform offers hundreds of custom configurations and integrates deeply within client procurement, compliance and finance systems. This unique platform architecture allows for implementation in days.

“We are thrilled to be a 2022 BioTech Breakthrough award winner,” said Chris Petersen, Founder and CTO at Scientist.com. “By eliminating paperwork and bureaucracy and creating a more automated and intelligent R&D process, Scientist.com is helping drive tomorrow’s great discoveries, today.”

Scientist.com enables researchers to ‘do more with less’ by saving time, reducing costs, improving access to innovation and ensuring compliance with internal and external regulations. Researchers using Scientist.com have instant access to the world’s largest laboratory network, including over 4,000 CROs and academic labs, which offer tens of thousands of innovative tools, technologies and lab supplies.

“Scientist.com was chosen among numerous applicants for providing a solution to some of the biggest problems facing research organizations today, including a decline in R&D efficiency and the rising cost of bringing new products to market,” said Bryan Vaughn, Managing Director of BioTech Breakthrough Awards. “The Scientist.com platform allows researchers to focus their attention on carrying out game-changing R&D that can dramatically improve research success. Congratulations to them for being our choice for ‘Overall BioPharma Solution of the Year.’”

The mission of the annual BioTech Breakthrough Awards program is to conduct the industry’s most comprehensive analysis and evaluation of the top companies, solutions and products in the life sciences and biotechnology industry today. This year’s program attracted more than 1,350 nominations from over 12 different countries throughout the world. A full list of 2022 BioTech Breakthrough Awards winners can be found at https://biotechbreakthroughawards.com/2022-winners/

About Scientist.com

Scientist.com’s mission is to empower and connect scientists worldwide. Our digital research platform combines sophisticated AI technology with white-glove Research Concierge support to enable scientists to run more innovative experiments in less time and at lower cost. Scientist.com operates private “business to enterprise” marketplaces for most of the world’s major pharmaceutical companies, over 100 biotechnology companies, and the US National Institutes of Health (NIH).

Join Scientist.com on social media: YouTube, LinkedIn, Twitter, Facebook and Instagram.

About BioTech Breakthrough

Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the BioTech Breakthrough Awards program is devoted to honoring excellence in life science and biotechnology solutions, services and companies. The BioTech Breakthrough Awards provide public recognition for the achievements of biotechnology companies and products in categories including BioPharma, Genomics, Therapeutics, Food Science and BioAgriculture, and more. For more information visit BioTechBreakthroughawards.com

Share article on social media or email:



[ad_2]

Amerisure Earns Metropolitan Detroit’s Best and Brightest Companies to Work For® Recognition

[ad_1]

“The Metro Detroit Best and Brightest award is a testament to the efforts of our employees and leadership, as well as our ability to deliver on our One Amerisure service model,” said Erin Buddie, vice president of human resources at Amerisure.

Amerisure Insurance Company has once again been recognized among the Metropolitan Detroit Best and Brightest Companies to Work For®. This year marks the 17th time Amerisure has been named to the prestigious list for Southeastern Michigan.

Participating organizations were evaluated and assessed based on categories such as communication, work-life balance, employee education, diversity, recognition and retention. The winning companies display “a commitment to excellence in their human resource practices and employee enrichment.”

“Amerisure succeeds as an organization due to the valuable contributions of our talented employees, and we’re proud to be recognized for our culture of collaboration and high levels of employee engagement,” said Erin Buddie, vice president of human resources at Amerisure. “The Metro Detroit Best and Brightest award is a testament to the efforts of our employees and leadership, as well as our ability to deliver on our One Amerisure service model.”

The Best and Brightest Companies to Work For® program is sponsored by The National Association for Business Resources (NABR) and celebrates organizations cultivating better business, creating richer lives and building stronger communities. Recipients of the annual Metro Detroit award will be recognized at a virtual celebration on November 9.

To see the full list of 2022 Metro Detroit recipients, click here.

In addition to the Best and Brightest Companies to Work For® in Metro Detroit award, Amerisure has also been named among the 2022 Best and Brightest Companies to Work For® in Atlanta and in the Nation and was recognized by Insurance Journal as a 2022 Super Regional Property/Casualty Insurer™.

About Amerisure Insurance

Amerisure is a leading provider of commercial property and casualty insurance solutions for U.S.-based construction, manufacturing and healthcare businesses. Licensed in all fifty states and available through an exclusive network of elite independent agents, the company upholds an “A” (Excellent) financial strength rating, industry-leading service scores, and multiple awards for innovation. Amerisure has been in business for more than 100 years and is consistently named among the best places to work in the industry and throughout the nation. To learn more, visit Amerisure.com.

Share article on social media or email:

[ad_2]

Patient Experience Journal, in Association with The Beryl Institute, Releases Volume 9, Issue 3

[ad_1]

The Beryl Institute announces the publication of Volume 9, Issue 3 of Patient Experience Journal (PXJ), an international, open access, peer-reviewed journal focused on research and proven practices related to understanding and improving the patient experience. Read in over 220 countries and territories, PXJ articles have been downloaded over one million times and reflects the journal’s commitment to disseminating rigorous knowledge and expanding the global conversation on evidence and innovation in patient and human experience.

Published in association with The Beryl Institute, Volume 9, Issue 3 includes 25 articles representing commentaries, personal narratives, research studies and case studies covering topics such as:

  • Living with brain cancer: From researcher to patient
  • The intersection of diversity, equity and inclusion with pediatric Patient and Family Advisory Councils
  • Patient experience of Electronic Health Records (EHR) in a maternity unit in Ireland
  • Going from academic medical center to a community hospital: Patient experiences with transfers
  • Home health care CAHPS® survey: Predicting patient experience performance
  • A patient perspective on information provision during the care path of Lentigo Maligna
  • Technology about me without me: An examination of the relationship between patient-facing technology and patient experience

The research represents a broad range of global organizations and institutions including Ann & Robert H. Lurie Children’s Hospital of Chicago, Cincinnati Children’s Hospital Medical Center, Deakin University Geelong. School of Nursing & Midwifery, Institute for Health Transformation, Centre for Quality & Patient Safety Research, Erasmus School of Health Policy and Management, Rotterdam, the Netherlands, Experience of Care Lead, NHS England and NHS Improvement, Florida State University College of Medicine, George Washington University Health.Links, Saudi Arabia, Katholieke Universiteit Leuven, Mayo Clinic, McMaster University, Medallia, QEII Jubilee Hospital, Royal Manchester Children’s Hospital, Sentara Healthcare, University College Cork, University of Alabama-Birmingham, University of California San Francisco, University of Oxford, University of Port Harcourt, University of Twente.

“As was known even prior to the pressures placed on us by the pandemic, what lied just beneath the surface of our work in healthcare was clear,” said Jason Wolf, Founding Editor of PXJ and President & CEO of The Beryl Institute. “…But amid this turbulent reality, I believe there is hope, a space for optimism and a solid foundation on which we can and must build. It is this commitment to action and a contribution to the larger conversation that we continue to see reflected on the pages of PXJ itself. In our final issue of 2022 and the close of Volume 9, we release one of our largest issues ever. We continue to hear from the voices of patients and care partners, clinicians and researchers, all committed to elevating the evidence and practice driving the healthcare experience.”

To access Volume 9, Issue 3 of PXJ, visit:http://pxjournal.org/journal

###

About Patient Experience Journal:

Patient Experience Journal (PXJ) is a peer-reviewed, open-access journal published in association with The Beryl Institute. Read in over 220 countries and territories, PXJ is committed to disseminating rigorous knowledge and expanding the global conversation on evidence and innovation on patient experience.

About The Beryl Institute:

The Beryl Institute is a global community of professionals and experience champions committed to transforming the human experience in healthcare. As a pioneer and leader of the experience movement and patient experience profession for more than a decade, the Institute offers unparalleled access to unbiased research and proven practices, networking and professional development opportunities and a safe, neutral space to exchange ideas and learn from others.

We define the patient experience as the sum of all interactions, shaped by an organization’s culture, that influence patient perceptions across the continuum of care. We believe human experience is grounded in the experiences of patients & families, members of the healthcare workforce and the communities they serve.

Share article on social media or email:

[ad_2]

Press Release News Wire Service